Procaps Group, S.A. (PROC) Social Stream



Procaps Group, S.A. (PROC): $4.39

0.07 (+1.62%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add PROC to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#44 of 167

in industry

PROCAPS GROUP SA (PROC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PROC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-08-31 1 $13 $13 $13 $4.4 195.45%
2022-11-16 1 $11 $11 $11 $4.4 150%
2023-05-16 1 $7 $7 $7 $4.4 59.09%
NA 1 $NA $NA $NA $4.4 NA%

Price Target Last Issued May 16, 2023

The Trend in the Analyst Price Target


Over the past 17 months, PROC's average price target has gone down $6.

Over the past 48 weeks, PROC's average upside potential has been 63.46%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-15 1 13 13 13 8.86 46.73%
2022-11-16 1 11 11 11 6.60 66.67%
2023-02-13 1 7 7 7 3.96 76.77%
2023-05-15 1 7 7 7 4.45 57.3%
2023-05-16 1 7 7 7 4.51 55.21%

PROC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 48 weeks, PROC's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how PROCAPS GROUP SA fares relative to all US stocks, note that its number of analysts covering the stock is greater than just about none of of that group.
  • PROCAPS GROUP SA's variance in analysts' estimates is lower than almost 100% of all US stocks.
  • In the context of Healthcare stocks, PROCAPS GROUP SA's average analyst price target is greater than 57.04% of them.
  • PROCAPS GROUP SA's upside potential (average analyst target price relative to current price) is greater than 163.16% of stocks in the small market cap category.

In the Pharmaceutical Products industry, COLL, AKBA, and EGRX are the three stocks most similar to PROCAPS GROUP SA regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding PROC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6768 seconds.